医疗设备制造商Revvity（RVTY）今日盘前大跌5.45%，引发市场关注。截至盘前交易，该公司股价下跌至93.5美元。
这一显著跌幅主要源于公司发布的第三季度财报未能达到市场预期。根据LSEG数据，Revvity第三季度营收为6.99亿美元，低于分析师预期的7.005亿美元。这一营收数据的不及预期成为打压股价的主要因素。
然而，值得注意的是，公司在其他方面表现出一定韧性。Revvity报告的第三季度每股利润为1.18美元，高于分析师平均预期的1.14美元。此外，公司重申了2-4%的有机增长目标，并将年度每股收益预期从之前的4.85美元至4.95美元上调至4.90美元至5.00美元。同时，公司董事会还批准了一项新的10亿美元股票回购计划，以替代此前宣布的计划。这些积极因素可能在一定程度上缓解了投资者的担忧，但目前看来，市场更关注公司的营收表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.